Sydney offers a research-intensive 4-year graduate MD anchored at Royal Prince Alfred, Westmead, Concord, and Nepean clinical schools, with a mandatory independent research project woven through years 2-4 and strong placement breadth across metropolitan, regional, and rural NSW.
What makes it different
Sydney runs a 4-year graduate-entry MD with a mandatory MD Independent Research Project woven through years 2-4. Standard pathway is GAMSAT-only — no interview since 2021. The Cadigal Program (run via the IAAG / Indigenous Admissions Advisory Group) offers a dedicated entry pathway for Aboriginal and Torres Strait Islander applicants, with the GPA floor relaxed to support improvement trajectories.
Course & teaching
Case-based curriculum. 4-year graduate MD. Themes interleave basic and clinical sciences from week 1: Foundations, Patient & Doctor, Community & Doctor, Personal & Professional Development. Hospital-based years 3-4 with regional and rural electives.
Research strengths
Sydney has notable research strength in Cardiovascular medicine, Cancer biology, Neuroscience, Indigenous health, Infectious disease.
Interview
Sydney interviews via GAMSAT-only ranking for standard pathway (no interview since 2021); Cadigal Program uses bespoke MMI. Since the 2021 entry cycle Sydney MD has had no interview for the standard pathway — offers are based on GAMSAT alone, with USyd ranking applicants on individual section scores (Section 1 → Section 2 → Section 3) rather than the overall weighted score. GAMSAT results must be from the past two years (shorter than ACER's 4-year validity). Aboriginal and Torres Strait Islander applicants enter through the IAAG/Cadigal Program which uses a bespoke MMI.
Intake
~300 domestic (210 CSP + 90 BMP) + ~70-80 international (Metropolitan stream) = ~370-380 total per year (Fraser's aggregated from USyd MD Offer Preferences PDF).
At a glance
Founded in 1856, based in Sydney. Programmes offered: Clinical Research, Global Health, Indigenous Health, Rural Medicine, Infectious Disease.